Genertec Universal Medical : APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GENERTEC UNIVERSAL MEDICAL GROUP COMPANY

LIMITED

通用環球醫療集團有限公司

(Incorporated in Hong Kong with limited liability)

(Stock Code：2666)

APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

AND

CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE

The Board is pleased to announce that with effect from 2 December 2019, Mr. Liao Xinbo was appointed as an independent non-executive Director and a member of the Nomination Committee.

APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

The board (the "Board") of directors (the "Directors", and each a "Director") of Genertec Universal Medical Group Company Limited (the "Company") is pleased to announce that with effect from 2 December 2019, Mr. Liao Xinbo ("Mr. Liao") was appointed as an independent non- executive Director and a member of the Board's nomination committee (the "Nomination Committee").

Mr. Liao Xinbo (廖新波), aged 63, is a member of the core experts group of China Alliance for Patient Safety (中國患者安全聯盟核心專家組), an expert of the national think tank of Xinhuanet Health China Promotion Working Committee (新華網健康中國促進工作委員會國家智庫), a

1

deputy director (副主任委員) of the Intelligent Medicine Professional Committee of the Chinese Medical Doctor Association (中國醫師協會智慧醫療專業委員會), and the director (主任) of the Research Center of Medical Behavior in Shanghai Jiaotong University (上海交通大學醫療行為研 究中心). From December 1982 to February 2004, Mr. Liao worked in Guangdong Provincial People's Hospital (廣東省人民醫院), engaged in clinical pathology for 11 years and then hospital management for another 11 years. He served in the Department of Health of Guangdong Province (廣東省衛生廳) for 12 years, holding positions as deputy director (副廳長) and inspector (巡視員), and later served as a deputy director (副主任) of Health and Family Planning Commission of Guangdong Province (廣東省衛生和計劃生育委員會). Mr. Liao graduated from the Medical Department of Guangzhou Medical College (currently known as Guangzhou Medical University) with a bachelor's degree in 1982, obtained a master's degree from China Europe International Business School in 2003 and a master's degree in advanced hospital administration from Lingnan (University) College of Sun Yat-Sen University in 2005.

Mr. Liao and the Company entered into an appointment letter on 2 December 2019, pursuant to which Mr. Liao was appointed since 2 December 2019, and such appointment could be terminated by either Mr. Liao or the Company by giving not less than three months' notice in writing. Mr. Liao will hold office until completion of the next annual general meeting of the Company following his appointment, and will then be eligible for re-election at that general meeting. If Mr. Liao would be re-elected at the Company's next annual general meeting, he will be subject to the requirements under the articles of association of the Company regarding retirement by rotation and re-election at the annual general meeting of the Company. Mr. Liao, pursuant to the appointment letter, is entitled to a director's fee of HK$200,000 per annum which was determined by the Board with reference to his duties and responsibilities as well as prevailing market rates.

As at the date of this announcement, Mr. Liao did not (i) have any relationship with any Directors, senior management or substantial or controlling shareholders of the Company; (ii) have any interest in the shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong); (iii) hold any other directorships in public companies the securities of which are listed on any securities market in Hong Kong or overseas in the last three years; and (iv) hold other positions with the Company or its subsidiaries.

Save as disclosed above, to the best of the knowledge, information and belief of the Directors after having made all reasonable enquiries, there is no information in relation to the appointment of Mr. Liao that is required to be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and there is no other matter that needs to be brought to the attention of the shareholders of the Company.

The Board would like to extend its warm welcome to Mr. Liao's role as an independent non- executive Director.

2

CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE

The Board would like to announce that with effect from 2 December 2019, Mr. Liao was appointed as a member of the Nomination Committee. Upon Mr. Liao's appointment, the Nomination Committee comprises the following Directors:

• Mr. Zhang Yichen (chairman of the committee and non-executive Director)
• Mr. Chow Siu Lui (independent non-executive Director)
• Mr. Liao Xinbo (independent non-executive Director)

By order of the Board

Genertec Universal Medical Group Company

Limited

通用環球醫療集團有限公司

Peng Jiahong

Executive Director

Beijing, PRC, 2 December 2019

As at the date of this announcement, the executive Directors are Ms. Peng Jiahong (Vice- chairwoman) and Mr. Yu Gang; the non-executive Directors are Mr. Zhang Yichen (Chairman), Ms. Liu Kun, Mr. Liu Zhiyong, Mr. Liu Xiaoping and Mr. Su Guang; and the independent non-executive Directors are Mr. Li Yinquan, Mr. Chow Siu Lui, Mr. Han Demin and Mr. Liao Xinbo.

3